Jolien Perneel, Belgium

  • Clinical (3)

    PB6.2: Increased levels of TMEM106B lead to lysosomal dysfunction and aberrant neurotrophin signaling in mice

    Date: 21 Sep 2024Time: 17:34 - 17:38 CET